10 results
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... Loop #Thiazide #CHF ... #Cardiology #Management
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Arrhythmias / CHB ... Extreme Dehydration, Severe ... vasoactive drug pharmacology ... inopressors #diagnosis #management ... #comparison #table
Intern Pocket Cards - Inpatient Blood Pressure Management Guide
ß-blockers:
 • Metoprolol, Carvedilol, Labetalol
 • Bradycardia, heart
Blood Pressure Management ... Clonidine • Severe ... unpredictable drop in SBP Partial ... medications #Inpatient #pharmacology ... agents #internship #comparison
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
weaknesses, and adverse ... tolerable • CSF ... #valleyfever #management ... #antifungals #comparison ... #table #pharmacology
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
Atrial Fibrillation ... decompensated CHF ... patients with severe ... #Medications #management ... #treatment #comparison
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Atrial Fibrillation ... Decompensated HF ... • Moderate or severe ... AFib #diagnosis #management ... #cardiology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
weaknesses, and adverse ... - Weaknesses: CSF ... Benefits: High CSF ... #pharmacology # ... management #treatment
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
differential #algorithm #management ... #cardiology #treatment ... #heartfailure #chf ... #criticalcare # ... icu #clinical #pharmacology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
May have typical HF ... Management during ... , prevents the release ... Serial TTE and close ... #cardiology #treatment
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
to ask) - Any adverse ... disease b) CHF ... one post op Cardiology ... CARP, DECREASE V trials ... medical and surgical management